Correlation of Genetic Patterns with Tumor Biology and Survival Outcome in Renal Cell Carcinoma: A Combined Prospective and Retrospective Study
International Journal of Pharmaceutical Quality Assurance · 10.07.2026 · 16 (11)
DOI: 10.25258/ijpqa.16.11.55 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 10.07.2026. Verfasst von Kuppurajan Narayanasamy und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Renal cell carcinoma (RCC) is a heterogeneous malignancy with diverse genetic alterations, variable ‘ tumor biology, and differences in clinical presentation across age groups. Although age-related clinical patterns are recognized, the clinical utility of genetic testing across different tumor characteristics remains incompletely defined.
Aim
To evaluate the association between genetic patterns, tumor biology, and clinical outcomes in RCC, and to assess the role of selective genetic testing based on tumor laterality and focality. Methodology: This study included RCC patients treated between 2013 and 2024 in the retrospective cohort and newly diagnosed cases enrolled prospectively. Comprehensive clinical, demographic, radiological, surgical, pathological, and genetic data were collected. Whole-exome sequencing was performed in patients aged ≤46 years and those with familial, bilateral, or multifocal renal tumors. Statistical analysis was conducted using SPSS version 22, with a significance threshold of p < 0.05.
Results
A total of 167 patients were analyzed. Older patients demonstrated a higher burden of comorbidities, whereas younger patients more frequently presented with early-stage disease. Clinical presentation, tumor laterality, and surgical approaches were comparable between age groups. Pathogenic genetic mutations were predominantly identified in patients with bilateral multifocal tumors and in rare aggressive histological subtypes such as primitive neuroectodermal tumor and SDH-deficient RCC. No pathogenic genetic alterations were detected in bilateral unifocal tumors.
Conclusion
The diagnostic yield of genetic testing appears higher in selected high-risk RCC subgroups, particularly bilateral multifocal tumors and rare aggressive variants. A selective, risk-based approach to genetic evaluation may aid in risk stratification and individualized patient management.
Zitieren
APA
Narayanasamy, K., Thakare, V., Kumar, M. P., Anandan, M., & Mehta, S. (2026). Correlation of Genetic Patterns with Tumor Biology and Survival Outcome in Renal Cell Carcinoma: A Combined Prospective and Retrospective Study. International Journal of Pharmaceutical Quality Assurance, 16(11). https://doi.org/10.25258/ijpqa.16.11.55
Vancouver
Narayanasamy K, Thakare V, Kumar MP, Anandan M, Mehta S. Correlation of Genetic Patterns with Tumor Biology and Survival Outcome in Renal Cell Carcinoma: A Combined Prospective and Retrospective Study. International Journal of Pharmaceutical Quality Assurance. 2026;16(11). doi:10.25258/ijpqa.16.11.55
BibTeX
@article{Narayanasamy2026,
author = {Narayanasamy, Kuppurajan and Thakare, Vaibhav and Kumar, M. Pradeep and Anandan, M. and Mehta, Sangeetha},
title = {Correlation of Genetic Patterns with Tumor Biology and Survival Outcome in Renal Cell Carcinoma: A Combined Prospective and Retrospective Study},
journal = {International Journal of Pharmaceutical Quality Assurance},
year = {2026},
volume = {16},
number = {11},
doi = {10.25258/ijpqa.16.11.55}
}
EUVIMED